Amicus Therapeutics SG&A Expense (Quarterly) Insights

Amicus Therapeutics Inc (FOLD)

9.57 +0.07 (+0.74%) USD | NASDAQ | May 17, 16:00

9.58 +0.01 (+0.10%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	88.03M
December 31, 2023	70.24M
September 30, 2023	65.65M
June 30, 2023	65.42M
March 31, 2023	73.96M
December 31, 2022	54.27M
September 30, 2022	47.27M
June 30, 2022	53.38M
March 31, 2022	58.12M
December 31, 2021	57.60M
September 30, 2021	46.11M
June 30, 2021	42.28M
March 31, 2021	46.73M
December 31, 2020	43.68M
September 30, 2020	37.85M
June 30, 2020	34.66M
March 31, 2020	40.22M
December 31, 2019	43.30M
September 30, 2019	39.68M
June 30, 2019	42.58M
March 31, 2019	44.30M
December 31, 2018	38.76M
September 30, 2018	31.87M
June 30, 2018	29.17M
March 31, 2018	27.40M

Date	Value
December 31, 2017	28.58M
September 30, 2017	21.65M
June 30, 2017	19.31M
March 31, 2017	19.13M
December 31, 2016	18.68M
September 30, 2016	17.47M
June 30, 2016	19.30M
March 31, 2016	15.70M
December 31, 2015	17.19M
September 30, 2015	15.37M
June 30, 2015	8.278M
March 31, 2015	6.427M
December 31, 2014	5.518M
September 30, 2014	5.27M
June 30, 2014	4.753M
March 31, 2014	5.176M
December 31, 2013	4.605M
September 30, 2013	4.635M
June 30, 2013	4.83M
March 31, 2013	4.823M
December 31, 2012	4.455M
September 30, 2012	4.995M
June 30, 2012	5.819M
March 31, 2012	4.095M
December 31, 2011	3.917M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

34.66M

Minimum

Jun 2020

88.03M

Maximum

Mar 2024

52.55M

Average

47.00M

Median

SG&A Expense (Quarterly) Benchmarks